Patent · US Active

Laser-induced transepidermal elimination of content by fractional photothermolysis

US8690863B2 · kind B2 · utility

41Cited by
12References
39Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 10, 2006
Grant dateApr 8, 2014
Priority date
Expiry dateFeb 6, 2033

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61B2018/00452
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

Subjects treated with nonablative fractional photothermolysis (FP) have an intact stratum corneum, but can have microscopic lesions and vacuole formation within the epidermis. The vacuoles thus formed can trap dermal material and extrude it through the epidermis. Thus, FP can be used for the treatment of recalcitrant melasma, solar elastosis, and tattoos.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.